Does LUBIPROSTONE Cause Hepatic function abnormal? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Hepatic function abnormal have been filed in association with LUBIPROSTONE (Amitza). This represents 1.8% of all adverse event reports for LUBIPROSTONE.
22
Reports of Hepatic function abnormal with LUBIPROSTONE
1.8%
of all LUBIPROSTONE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Hepatic function abnormal From LUBIPROSTONE?
Of the 22 reports, 8 (36.4%) required hospitalization, and 3 (13.6%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LUBIPROSTONE. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does LUBIPROSTONE Cause?
Diarrhoea (170)
Drug ineffective (131)
Nausea (110)
Constipation (82)
Vomiting (75)
Dizziness (59)
Abdominal distension (57)
Dyspnoea (53)
Headache (47)
Abdominal pain (45)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which LUBIPROSTONE Alternatives Have Lower Hepatic function abnormal Risk?
LUBIPROSTONE vs LUCENTIS
LUBIPROSTONE vs LUCRIN DEPOT
LUBIPROSTONE vs LUMASIRAN
LUBIPROSTONE vs LUMATEPERONE
LUBIPROSTONE vs LUMIGAN